Drug · DIN 02524309
BENVYON
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since January 30, 2023; first marketed January 30, 2023.
- Drug Identification Number (DIN)
- 02524309
- Company (DIN owner)
- Pfizer Canada UlcKirkland, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Bendamustine L01AA09
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| BENDAMUSTINE HYDROCHLORIDE | 25 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- January 14, 2022: NOC 27402New Drug Submission (NDS)